scispace - formally typeset
G

Gideon Koren

Researcher at Ariel University

Publications -  2007
Citations -  88165

Gideon Koren is an academic researcher from Ariel University. The author has contributed to research in topics: Pregnancy & Population. The author has an hindex of 129, co-authored 1994 publications receiving 81718 citations. Previous affiliations of Gideon Koren include McGill University Health Centre & University of Western Ontario.

Papers
More filters
Journal ArticleDOI

Proximity effect in YBa2Cu3O7/Y0.6Pr0.4Ba2Cu3O7/YBa2Cu3O7 junctions

TL;DR: In this article, critical-current measurements for superconducting-normal superconductor junctions were performed using normal metal as the normal metal and showed that the order-parameter decay length is about 120 \AA{} for Tg60 K, and it diverges as the threshold is approached.
Journal Article

Neurodevelopment of adopted children exposed in utero to cocaine

TL;DR: This is the first study to document that intrauterine exposure to cocaine is associated with measurable and clinically significant toxic neurologic effects, independent of postnatal home and environmental confounders.
Journal ArticleDOI

Fentanyl pharmacokinetics and hemodynamic effects in preterm infants during ligation of patent ductus arteriosus.

TL;DR: A bolus of 30 μg·kg−1 fentanyl was given to nine preterm infants for induction of anesthesia for ligation of a patent ductus arteriosus, and most infants moved and breathed spontaneously at the end of surgery, suggesting redistribution of fentanyl from brain into pharmacodynamically inert tissues.
Journal ArticleDOI

Functional scaffold-free 3-D cardiac microtissues: a novel model for the investigation of heart cells.

TL;DR: A novel scaffold-free cardiac 3-D culture model with several advancements for the investigation of CM and CF function and cross-regulation is developed and cell type-specific adenoviral gene transfer was achieved.
Journal ArticleDOI

Antidepressant use during pregnancy: the benefit-risk ratio

TL;DR: This review aims at presenting an updated analysis of fetal and maternal exposure to selective serotonin or norepinephrine reuptake inhibitors to allow an evidence-based benefit:risk ratio.